Article info
Review
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
- Correspondence to Michel Michaelides, UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; michel.michaelides{at}ucl.ac.uk
Citation
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Publication history
- Received April 4, 2016
- Revised June 20, 2016
- Accepted July 11, 2016
- First published August 4, 2016.
Online issue publication
December 14, 2016
Article Versions
- Previous version (4 August 2016).
- Previous version (28 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/